Whitmore Lake, MI, United States of America

Timothy Thomas Curran

USPTO Granted Patents = 6 

Average Co-Inventor Count = 9.2

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2004-2008

Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovations of Timothy Thomas Curran

Introduction

Timothy Thomas Curran is a notable inventor based in Whitmore Lake, MI (US). He has made significant contributions to the field of pharmaceuticals, holding a total of 6 patents. His work primarily focuses on the synthesis of compounds that have therapeutic applications.

Latest Patents

Among his latest patents is a process for the synthesis of derivatives of halo-[2,3-F] quinoline. This patent outlines methods for preparing compounds that are crucial in various medical applications. Another significant patent involves amino acids with affinity for the α2δ-protein. This patent discloses certain β-amino acids that bind to the alpha-2-delta (α2δ) subunit of a calcium channel, which are useful in treating a variety of psychiatric, pain, and other disorders. The methods of making these β-amino acids are also detailed in this patent.

Career Highlights

Throughout his career, Timothy has worked with prominent companies such as Wyeth and Warner-Lambert Company. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.

Collaborations

Timothy has collaborated with notable individuals in his field, including Silvio Iera and Warren Chew. Their combined efforts have led to advancements in the development of therapeutic compounds.

Conclusion

Timothy Thomas Curran's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the treatment of various disorders, showcasing the importance of innovation in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…